Nurse Practitioner, Primary Care · Louisville, KY
NPI
1548632722
Since 2015
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3999 Dutchmans Ln Ste 2f
Louisville, KY, 40207
Phone (502) 883-0227
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
2,214 services
Medicare patients, 2024
367
Average age 73
Drug cost, 2024
$4.1M
6,789 prescriptions
Company payments, 2025
$12K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica Goettl was code 99214 (office e&m - established), 769 times for 340 patients. In total Jessica Goettl billed 2,214 services in 9 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 769 | 340 | $74.43 | $57K |
| 95251 Test - Miscellaneous | Office | 259 | 123 | $22.47 | $5,819 |
| 99213 Office E&M - Established | Office | 47 | 40 | $53.29 | $2,504 |
By year: 2022 $59K for 955 services; 2023 $61K for 1,040 services; 2024 $70K for 2,214 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica Goettl prescribed most often to Medicare patients was Levothyroxine Sodium, with 564 prescriptions and refills. In total Jessica Goettl wrote 6,789 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 564 | 1,505 | 159 | $5,660 |
| Rosuvastatin Calcium Generic | 284 | 738 | 89 | $2,787 |
| Jardiance Empagliflozin | 284 | 640 | 70 | $369K |
| Synthroid Levothyroxine Sodium | 281 | 701 | 72 | $22K |
| Atorvastatin Calcium Generic | 267 | 745 | 89 | $1,941 |
| Mounjaro Tirzepatide | 261 | 326 | 46 | $337K |
| Trulicity Dulaglutide | 249 | 447 | 65 | $435K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 237 | 570 | 80 | $57K |
| Metformin Hcl Er Metformin Hcl | 229 | 628 | 75 | $2,144 |
| Ozempic Semaglutide | 221 | 381 | 54 | $365K |
| Metformin Hcl Generic | 221 | 602 | 69 | $1,539 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 212 | 516 | 68 | $377K |
| Tresiba Flextouch U-100 Insulin Degludec | 202 | 503 | 66 | $181K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 178 | 475 | 74 | $21K |
| Tresiba Flextouch U-200 Insulin Degludec | 176 | 417 | 57 | $297K |
Brand drugs: 4,148 claims; generic drugs: 2,106 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica Goettl $12K ($12K in general payments such as food, travel and fees) from 8 companies. The largest payer was Insulet Corporation with $12K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.